1. Home
  2. BAND vs PRTC Comparison

BAND vs PRTC Comparison

Compare BAND & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bandwidth Inc.

BAND

Bandwidth Inc.

HOLD

Current Price

$14.73

Market Cap

427.6M

Sector

Technology

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$16.79

Market Cap

386.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAND
PRTC
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
427.6M
386.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BAND
PRTC
Price
$14.73
$16.79
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$20.80
N/A
AVG Volume (30 Days)
186.8K
4.7K
Earning Date
10-30-2025
08-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$756,118,000.00
$6,391,000.00
Revenue This Year
$2.82
N/A
Revenue Next Year
$15.10
N/A
P/E Ratio
N/A
$7.65
Revenue Growth
7.42
1265.60
52 Week Low
$11.33
$13.30
52 Week High
$21.08
$23.69

Technical Indicators

Market Signals
Indicator
BAND
PRTC
Relative Strength Index (RSI) 50.85 51.25
Support Level $13.75 $16.42
Resistance Level $14.46 $16.83
Average True Range (ATR) 0.53 0.31
MACD 0.13 0.10
Stochastic Oscillator 87.50 58.99

Price Performance

Historical Comparison
BAND
PRTC

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: